KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Income from Non-Controlling Interests (2020 - 2025)

AbbVie (ABBV) has disclosed Income from Non-Controlling Interests for 6 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Income from Non-Controlling Interests fell 33.33% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $7.0 million, a 36.36% decrease, with the full-year FY2024 number at $8.0 million, down 20.0% from a year prior.
  • Income from Non-Controlling Interests was $2.0 million for Q3 2025 at AbbVie, down from $3.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of $4.0 million in Q2 2022 to a low of -$1.0 million in Q4 2022.
  • A 5-year average of $2.3 million and a median of $3.0 million in 2022 define the central range for Income from Non-Controlling Interests.
  • Peak YoY movement for Income from Non-Controlling Interests: soared 300.0% in 2023, then plummeted 150.0% in 2024.
  • AbbVie's Income from Non-Controlling Interests stood at $2.0 million in 2021, then tumbled by 150.0% to -$1.0 million in 2022, then skyrocketed by 300.0% to $2.0 million in 2023, then tumbled by 150.0% to -$1.0 million in 2024, then skyrocketed by 300.0% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Income from Non-Controlling Interests are $2.0 million (Q3 2025), $3.0 million (Q2 2025), and $3.0 million (Q1 2025).